Burden of chemotherapy-induced myelosuppression among patients with ES-SCLC in US community oncology settings Supplementary materials</p
Breast cancer has become a major surgical burden in Nigeria as in other developing countries. Unlike...
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of per...
Purpose: Neutropenic complications (NCs) after myelosup-pressive chemotherapy are associated with si...
AIMS: Chemotherapy-induced myelosuppression, which commonly exhibits as neutropenia, anemia, or thro...
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induc...
Background: Myelosuppression is a common side effect of chemotherapy (CT) that can compromise patien...
Supplemental Material for Predictive Model of Chemotherapy-Induced Myelosuppression for Patients wit...
OBJECTIVES: Chemotherapy induced myelosuppression (CIM), usually manifested as neutropenia, anemia a...
Given the few resources available to complement patient teaching on the subject of chemotherapy-indu...
Purpose: To evaluate the frequency of chemotherapy-induced myelotoxicity in cancer patients, the rel...
BACKGROUND: Supportive care interventions used to manage chemotherapy-induced myelosuppression (CIM)...
<p>Supplemental material, Supplemental_Material_for_Multiplexed_Myelosuppression_Assay_by_Javarappa,...
BACKGROUND: Multiple myeloma (MM) is a plasma cell tumor characterized by bone destruction, end orga...
Objective: Concomitant chemoradiotherapy (CRT) is the standard treatment for patients with stage III...
During cancer therapy, patients undergo long-term treatment with chemotherapists. Unfortunately, alt...
Breast cancer has become a major surgical burden in Nigeria as in other developing countries. Unlike...
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of per...
Purpose: Neutropenic complications (NCs) after myelosup-pressive chemotherapy are associated with si...
AIMS: Chemotherapy-induced myelosuppression, which commonly exhibits as neutropenia, anemia, or thro...
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induc...
Background: Myelosuppression is a common side effect of chemotherapy (CT) that can compromise patien...
Supplemental Material for Predictive Model of Chemotherapy-Induced Myelosuppression for Patients wit...
OBJECTIVES: Chemotherapy induced myelosuppression (CIM), usually manifested as neutropenia, anemia a...
Given the few resources available to complement patient teaching on the subject of chemotherapy-indu...
Purpose: To evaluate the frequency of chemotherapy-induced myelotoxicity in cancer patients, the rel...
BACKGROUND: Supportive care interventions used to manage chemotherapy-induced myelosuppression (CIM)...
<p>Supplemental material, Supplemental_Material_for_Multiplexed_Myelosuppression_Assay_by_Javarappa,...
BACKGROUND: Multiple myeloma (MM) is a plasma cell tumor characterized by bone destruction, end orga...
Objective: Concomitant chemoradiotherapy (CRT) is the standard treatment for patients with stage III...
During cancer therapy, patients undergo long-term treatment with chemotherapists. Unfortunately, alt...
Breast cancer has become a major surgical burden in Nigeria as in other developing countries. Unlike...
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of per...
Purpose: Neutropenic complications (NCs) after myelosup-pressive chemotherapy are associated with si...
DOI
Add to ORKG